These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11129118)

  • 1. A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis.
    Shimojo N; Arima T; Yamaguchi K; Kikuoka S; Kohn LD; Kohno Y
    Int Rev Immunol; 2000; 19(6):619-31. PubMed ID: 11129118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
    Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
    Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of Graves' hyperthyroidism.
    Seetharamaiah GS
    Autoimmunity; 2003; 36(6-7):381-7. PubMed ID: 14669945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.
    Shimojo N; Kohno Y; Yamaguchi K; Kikuoka S; Hoshioka A; Niimi H; Hirai A; Tamura Y; Saito Y; Kohn LD; Tahara K
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11074-9. PubMed ID: 8855311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [No Abstract]   [Full Text] [Related]  

  • 6. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
    Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
    Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease.
    Kala M; Chen CR; McLachlan SM; Rapoport B; Aliesky H; Chapman HA
    Immunology; 2005 Dec; 116(4):532-40. PubMed ID: 16313367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
    Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
    McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
    PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
    Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.
    McLachlan SM; Rapoport B
    Endocrine; 2019 Nov; 66(2):137-148. PubMed ID: 31560118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters.
    Ando T; Imaizumi M; Graves P; Unger P; Davies TF
    Endocrinology; 2003 Feb; 144(2):671-80. PubMed ID: 12538630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.
    Muehlberg T; Gilbert JA; Rao PV; McGregor AM; Banga JP
    Endocrinology; 2004 Apr; 145(4):1539-45. PubMed ID: 14764633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
    Pichurin PN; Chazenbalk GD; Aliesky H; Pichurina O; Rapoport B; McLachlan SM
    Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into Graves' hyperthyroidism from animal models.
    McLachlan SM; Nagayama Y; Rapoport B
    Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines, IgG subclasses and costimulation in a mouse model of thyroid autoimmunity induced by injection of fibroblasts co-expressing MHC class II and thyroid autoantigens.
    Yan XM; Guo J; Pichurin P; Tanaka K; Jaume JC; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2000 Nov; 122(2):170-9. PubMed ID: 11091271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
    Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
    J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.